New drug combo aims to outsmart tough colorectal cancer
Disease control
Recruiting now
This study tests whether adding a new drug called isunakinra to the immunotherapy pembrolizumab can help treat advanced colorectal cancer that has not responded to other treatments. The trial will enroll 20 people with a specific type of tumor (MSS, TMB-H, KRAS-mutated). Research…
Phase: PHASE2 • Sponsor: Buzzard Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC